AutoPiX is a major international project focused on improving healthcare for people with rheumatic and musculoskeletal diseases (RMDs).
The AutoPiX project brings together pharmaceutical and medical technology partners with leading academic institutions to enhance the use of imaging biomarkers for patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA), collectively known as systemic arthritides.
It aims to develop advanced imaging tools and artificial intelligence (AI) models to better diagnose, monitor, and treat these conditions. These tools will make use of imaging biomarkers—like X-rays, ultrasounds, and MRIs—to provide more precise and personalised care.
Medizinische Universität Wien
Chair of Rheumatology, Head of Division of Rheumatology
Prof. Dr Daniel Aletaha
Assoc. Prof. Dr Peter Mandl
https://www.meduniwien.ac.at/web/
Janssen Pharmaceutica NV (Johnson & Johnson)
Director, Digital Measurement Strategy
Robert Janiczek, PhD
https://innovativemedicine.jnj.com/
communication@autopix-project.eu
EURICE GmbH
Yuliia Hornitska
https://eurice.eu